MedPath

Cyberknife Radiosurgery and Quality of Life

Terminated
Conditions
Bone Cancer
Central Nervous System Cancer
Registration Number
NCT01163539
Lead Sponsor
Stanford University
Brief Summary

The purpose of this study is to look at pain control and QOL improvement after treatment with CK Radiosurgery for spinal metastases.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery.
  • There are no age or gender restrictions.
  • There are no life expectancy restrictions.
  • Karnofsky Performance Status greater than 40.
  • Negative pregnancy test or clinically assessed as not pregnant.
  • Ability to understand and the willingness to sign a written informed consent document.
Read More
Exclusion Criteria
  • Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.)
  • Other investigational medications or treatments will be noted, but will not preclude inclusion.
  • Pregnant or nursing patients will be not be included in the study due to radiation exposure.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath